Subxiphoid pericardial window for pericardial effusive disease.
A subxiphoid pericardial window made in 123 patients allowed drainage and diagnosis of pericardial effusions. In 40 patients with malignancy and effusions, median drainage was 450 ml; cytology was positive in 17 or 36 (47%), and pericardial biopsy showed cancer in 13 (43%) of 30 patients. In 11 patients with malignancy, both cytology of effusions and biopsy of the pericardium were negative. In 83 patients with benign effusions, median drainage was 400 ml. Effusions recurred in 14 of the 123 patients (11%); nine patients in the benign group and five in the malignant group. Five of these 14 underwent thoracotomy (3 to 542 days postoperatively); two underwent median sternotomy and one underwent pericardiocentesis. Two intraoperative deaths resulted from cardiac arrest. Mortality at 30 days was 25% (10/40 patients) in the malignant group and 11% (9/83 patients) in the benign group. No deaths resulted from recurrent effusions. The establishment of a subxiphoid pericardial window allows rapid and safe drainage of pericardial effusions with sampling for cytology and pericardial biopsy. It has minimal morbidity and few recurrent effusions.
Mills
S A
SA
Department of Surgery, Wake Forest University Medical Center, Winston-Salem, North Carolina.
Julian
S
S
Holliday
R H
RH
Vinten-Johansen
J
J
Case
L D
LD
Hudspeth
A S
AS
Tucker
W Y
WY
Cordell
A R
AR
D004322:Drainage / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010490:Pericardial Effusion / Q000209:etiology / Q000401:mortality / Q000601:surgery*; D010491:Pericardial Window Techniques; D012008:Recurrence; D012189:Retrospective Studies; D015996:Survival Rate; D014989:Xiphoid Bone / Q000601:surgery